Clinical Trial Update: Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing initial triple therapy including parenteral treprostinil versus initial double oral therapy in patients with pulmonary arterial hypert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• parenteral treprostinil (treprostinil)

Snippet

Sponsor: AOP Orphan Pharmaceuticals AG | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: RECRUITING